Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07447531 · ClinicalTrials.gov registry record · NA

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

A NA study of Malignant Glioma, sponsored by John M. Buatti.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07447531 is a NA study of Malignant Glioma that is actively recruiting participants, run by John M. Buatti. The registered enrollment target is 15 participants, below the 92-participant average among 40 other Malignant Glioma trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07447531, a NA study of Malignant Glioma, is actively recruiting participants, sponsored by John M. Buatti.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.

Conditions Studied

Malignant Glioma

Interventions

  • PROCEDURE Biospecimen Collection
  • PROCEDURE Magnetic Resonance Imaging
  • PROCEDURE T2 (Observed)-Weighted Imaging

Study Locations (1)

Iowa

  • University of Iowa Health Care - Iowa City

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-10-03
Est. Completion 2028-10-06
Phase NA

Sponsor

John M. Buatti

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07447531

The ClinicalTrials.gov registry entry for NCT07447531 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 40 other Malignant Glioma trials with a reported enrollment target (84% lower). The listed sponsor is John M. Buatti, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Glioma appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT07447531 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT07447531 about?

NCT07447531 is a clinical study titled "T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas". This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.

What is the current status of trial NCT07447531?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-10-03. Estimated completion is 2028-10-06.

What conditions does trial NCT07447531 study?

This clinical trial studies the following conditions: Malignant Glioma.

What interventions are being tested in trial NCT07447531?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), T2 (Observed)-Weighted Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT07447531?

This trial is sponsored by John M. Buatti, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07447531 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Glioma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Glioma

All registered trials for this condition

Iowa

All trials with a study site in Iowa

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.